+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Manufacturing Market - Global Forecast 2026-2032- Product Image
Pharmaceutical Manufacturing Market - Global Forecast 2026-2032- Product Image
New

Pharmaceutical Manufacturing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5896347
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical manufacturing market is undergoing rapid transformation as advanced technologies, evolving regulations, and dynamic trade policies shape new industry standards. For senior decision-makers, this pace of change demands focused strategies around investment, risk management, and operational flexibility to sustain market position.

Market Snapshot: Pharmaceutical Manufacturing Market Size and Trajectory

The pharmaceutical manufacturing market grew from USD 729.80 billion in 2025 to USD 785.42 billion in 2026 and is projected to reach USD 1.24 trillion by 2032, registering a CAGR of 7.90%. This growth reflects increased demand for biologic drugs and greater implementation of digital manufacturing platforms, positioning the market for strong expansion as operational models evolve.

Scope & Segmentation

  • Drug Types: Biosimilars, branded drugs, and generic drugs each influence manufacturing complexity, from cold-chain logistics and process control to oversight requirements.
  • Dosage Forms: Liquid, parenteral, and solid formulations such as capsules, powders, injectables, and vials, all drive unique workflow and compliance considerations.
  • Manufacturing Stages: API production, formulation, packaging, and labeling, each with distinct equipment and analytical controls requirements.
  • Molecule Classes: Large molecules require bioreactors and advanced purification, while small molecules rely on chemical synthesis and process optimization for quality assurance.
  • Manufacturing Technologies: Batch, continuous, and single-use systems shape validation protocols, facility infrastructure, and overall lifecycle cost analysis.
  • End-User Profiles: Biotechnology companies, CROs, government and public health agencies, pharmaceutical manufacturers, and academic or research institutions—each with differentiated production, compliance, and innovation priorities.
  • Therapeutic Focus: Oncology, infectious disease, and rare diseases necessitate specific capacity planning and tailored regulatory strategies.
  • Regional Coverage: North America, Europe-Middle East-Africa, and Asia-Pacific regions, each influencing facility siting, regulatory compliance, and supply chain design.

Key Takeaways for Senior Decision-Makers

  • Advanced manufacturing is increasingly converging with life sciences, moving novel therapies from research to large-scale production more rapidly.
  • Adoption of continuous and single-use manufacturing enables organizations to upgrade facilities with greater agility, influencing capital planning and asset management.
  • Regulatory agencies emphasize data integrity and process transparency, prompting investments in integrated digital quality systems and sophisticated analytics.
  • Regional variations in policy and infrastructure require robust, localized supply chains and nuanced regulatory strategies for compliance and agility.
  • Building adaptive supplier networks and modular investments is key for responding efficiently to changing market dynamics and volatility.

Tariff Impact: Navigating 2025 US Tariff Changes

New US tariffs create operational complexities for transnational supply chains in pharmaceutical manufacturing. These regulatory shifts prompt nearshoring, greater supplier diversification, and strategic sourcing to manage cost fluctuations and safeguard deliveries. Capital investment decisions now incorporate scenario planning to respond to evolving compliance requirements and jurisdictional shifts.

Methodology & Data Sources

This report integrates insights from executive interviews, proprietary industry engagement, and in-depth reviews of regulatory updates and technology adoption. Cross-disciplinary validation and scenario-based analysis ensure actionable and credible findings for senior decision-makers evaluating market direction.

The Pharmaceutical Manufacturing Market: Why This Report Matters

  • Detailed segmentation provides leadership teams with clear guidance for aligning investment with high-impact operational and clinical zones, strengthening strategic planning.
  • Strategic analysis highlights trends in technology deployment, resilient supply chain structures, and shifting regional influences, empowering risk mitigation and new market opportunities.

Utilize actionable insights from this report to refine operational priorities and sustain competitive positioning as market conditions rapidly evolve.

Conclusion

Organizations prioritizing flexible technologies, supplier diversification, and regulatory alignment will be positioned to mitigate risk and leverage market transformation. Strategic foresight and adaptation are vital to ensuring long-term growth as the pharmaceutical manufacturing sector continues to change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pharmaceutical Manufacturing Market, by Drug Type
8.1. Biosimilars
8.2. Branded Drugs
8.3. Generic Drugs
9. Pharmaceutical Manufacturing Market, by Molecule Type
9.1. Large Molecule Drugs
9.2. Small Molecule Drugs
10. Pharmaceutical Manufacturing Market, by Dosage Form
10.1. Liquid Dosage Forms
10.1.1. Solution
10.1.2. Suspension
10.2. Parenteral Dosage Forms
10.2.1. Infusion Forms
10.2.2. Injectable Forms
10.3. Solid Dosage Forms
10.3.1. Capsule
10.3.2. Powder
10.3.3. Tablet
10.4. Topical
10.4.1. Ointments
10.4.2. Creams
10.4.3. Gels
10.4.4. Lotions
10.5. Inhalation
10.6. Transdermal Patches
10.7. Ophthalmic Solutions
11. Pharmaceutical Manufacturing Market, by Manufacturing Stage
11.1. API Manufacturing
11.2. Formulation Manufacturing
11.3. Packaging & Labelling
12. Pharmaceutical Manufacturing Market, by Manufacturing Technology
12.1. Batch Manufacturing
12.2. Continuous Manufacturing
12.3. Single-Use Technology
13. Pharmaceutical Manufacturing Market, by Therapeutic Area
13.1. Cardiovascular
13.2. Gastroenterology
13.3. Immunology
13.4. Infectious Diseases
13.5. Neurology
13.6. Oncology
13.7. Respiratory
14. Pharmaceutical Manufacturing Market, by Age Group
14.1. Children & Adolescents
14.2. Adults
14.3. Geriatric
15. Pharmaceutical Manufacturing Market, by Distribution
15.1. Direct Sales
15.2. Wholesale / Distributors
15.3. Retail Pharmacy
15.4. Online / E-Commerce Pharmacies
15.5. Hospital Pharmacy Distribution
16. Pharmaceutical Manufacturing Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Pharmaceutical Manufacturing Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Pharmaceutical Manufacturing Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Pharmaceutical Manufacturing Market
20. China Pharmaceutical Manufacturing Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. Abbott Laboratories
21.6. AbbVie Inc.
21.7. Alkem Laboratories Ltd.
21.8. Amgen Inc.
21.9. Astellas Pharma Inc.
21.10. AstraZeneca plc
21.11. Aurobindo Pharma Ltd.
21.12. Baxter International Inc.
21.13. Bayer AG
21.14. Biogen Inc.
21.15. Boehringer Ingelheim GmbH
21.16. Bristol-Myers Squibb Company
21.17. Cipla Ltd.
21.18. Croda International Plc
21.19. CSL Limited
21.20. Divi’s Laboratories Ltd.
21.21. Dr. Reddy’s Laboratories Ltd.
21.22. Eli Lilly and Company
21.23. F. Hoffmann-La Roche Ltd.
21.24. Gilead Sciences, Inc.
21.25. GlaxoSmithKline plc
21.26. Johnson & Johnson Services, inc.
21.27. Lupin Ltd.
21.28. Mankind Pharma Ltd.
21.29. Merck KGaA
21.30. Novartis AG
21.31. Novo Nordisk A/S
21.32. Pfizer Inc.
21.33. Sanofi S.A.
21.34. Sun Pharmaceutical Industries Limited
21.35. Takeda Pharmaceutical Company Ltd.
21.36. Teva Pharmaceutical Industries Ltd.
21.37. Thermo Fisher Scientific Inc.
21.38. Torrent Pharmaceuticals Ltd.
21.39. Viatris Inc.
21.40. Zydus Lifesciences Ltd.
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LARGE MOLECULE DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LARGE MOLECULE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LARGE MOLECULE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SMALL MOLECULE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SMALL MOLECULE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFUSION FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFUSION FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFUSION FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LOTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LOTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LOTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OPHTHALMIC SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OPHTHALMIC SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OPHTHALMIC SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PACKAGING & LABELLING, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PACKAGING & LABELLING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PACKAGING & LABELLING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BATCH MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BATCH MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BATCH MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SINGLE-USE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SINGLE-USE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SINGLE-USE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY WHOLESALE / DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY WHOLESALE / DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY WHOLESALE / DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONLINE / E-COMMERCE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONLINE / E-COMMERCE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONLINE / E-COMMERCE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 199. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 203. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 204. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 205. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 206. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 207. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 208. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 210. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 211. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 225. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 227. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 228. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 229. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 230. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 231. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 232. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 233. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 234. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 236. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 237. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 254. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 255. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 256. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 257. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 258. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 259. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 260. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 261. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 263. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 264. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 265. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 267. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 268. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 269. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 270. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 271. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 272. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 273. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 274. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 276. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 277. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2032 (USD MILLION)
TABLE 291. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 293. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 294. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 295. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 296. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 297. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 298. BRIC

Companies Mentioned

The key companies profiled in this Pharmaceutical Manufacturing market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cipla Ltd.
  • Croda International Plc
  • CSL Limited
  • Divi’s Laboratories Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, inc.
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 785.42 Billion
Forecasted Market Value ( USD ) by 2032 $ 1240 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned37

Related Topics

Related Reports

Pharmaceutical Manufacturing Pipe Valve Parts Market - Global Forecast 2025-2030 - Product Image

Pharmaceutical Manufacturing Pipe Valve Parts Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Healthcare Contract Development & Manufacturing Organization Market - Global Forecast 2026-2032 - Product Image

Healthcare Contract Development & Manufacturing Organization Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Pharmaceutical Contract Development & Manufacturing Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Contract Development & Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
New Drug Approvals and Their Contract Manufacture: 2025 Edition - Product Image

New Drug Approvals and Their Contract Manufacture: 2025 Edition

  • Report
  • 86 Pages
  • Global
From
Continuous Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Drug Molecule, Stage of Bioprocessing, Type of Product Manufactured, Scale of Operation, Purpose of Manufacturing, Company Size, and Key Geographical Regions - Product Image

Continuous Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Drug Molecule, Stage of Bioprocessing, Type of Product Manufactured, Scale of Operation, Purpose of Manufacturing, Company Size, and Key Geographical Regions

  • Report
  • 481 Pages
  • Global
From

About the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing market is composed of companies that produce drugs and other pharmaceutical products. These products are used to treat and prevent diseases, as well as to improve the quality of life. Pharmaceutical manufacturers are responsible for the research, development, production, and distribution of these products. They must adhere to strict regulations and standards to ensure the safety and efficacy of their products. The Pharmaceutical Manufacturing market is highly competitive, with many large companies vying for market share. Some of the major players in the market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. These companies are involved in the research, development, production, and distribution of pharmaceutical products. They are also involved in the marketing and promotion of their products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.